.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Julphar
Novartis
Queensland Health
Merck
Cerilliant
Johnson and Johnson
Argus Health
Covington

Generated: November 23, 2017

DrugPatentWatch Database Preview

Bumetanide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bumetanide and what is the scope of bumetanide patent protection?

Bumetanide
is the generic ingredient in two branded drugs marketed by Sandoz, Teva Parenteral, Ivax Sub Teva Pharms, Validus Pharms, Hospira, Athenex Inc, and West-ward Pharms Int, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for bumetanide. Nineteen suppliers are listed for this compound.

Pharmacology for bumetanide

Medical Subject Heading (MeSH) Categories for bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Validus Pharms
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
BUMETANIDE
bumetanide
INJECTABLE;INJECTION074613-001Nov 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Athenex Inc
BUMETANIDE
bumetanide
INJECTABLE;INJECTION074441-001Jan 27, 1995APRXNoYes► Subscribe► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-001Feb 28, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
BUMETANIDE
bumetanide
INJECTABLE;INJECTION079196-001Apr 30, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
BUMETANIDE
bumetanide
TABLET;ORAL074225-002Apr 24, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
BUMETANIDE
bumetanide
TABLET;ORAL074700-002Nov 21, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
BUMETANIDE
bumetanide
INJECTABLE;INJECTION074332-001Oct 31, 1994APRXNoNo► Subscribe► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985ABRXYesNo► Subscribe► Subscribe► Subscribe
Sandoz
BUMETANIDE
bumetanide
TABLET;ORAL074700-003Nov 21, 1996ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-001Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-001Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Accenture
McKesson
Deloitte
Novartis
Baxter
Queensland Health
Federal Trade Commission
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot